MedImmune has opened a new, state-of-the-art pilot lab facility at its Gaithersburg site headquarters. The facility features the latest equipment and process automation systems and will support the company’s clinical product pipeline with additional capacity and flexibility. MedImmune, David M. Mott, president and chief executive officer, stated, “Completing this new facility is an important milestone, signaling our continued growth and success as a world-class biopharmaceutical...